Zobrazeno 31 - 40
of 147
pro vyhledávání: '"Michael Palese"'
Autor:
John Pfail, Olamide Omidele, Devki Shukla, Alexander C. Small, Michael Palese, Mark Finkelstein, Rebecca Klahr
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), is steadily increasing. A diagnosis of CKD/ESRD has been associated with adverse...
Publikováno v:
Journal of Urology. 206
Autor:
Osama Al-Alao, Devki Shukla, Michael Palese, Evan Garden, Susan Marshall, Craig Nobert, Alexander C. Small, Krishna Ravivarapu, Avinash Reddy, Micah Levy, Olamide Omidele, Robert Valenzuela, Steven Kaplan, Norman Coleburn, Jay A. Motola, Mantu Gupta
Publikováno v:
Journal of Urology. 206
Autor:
Greg Hruby, Osama Al-Alao, Darren Deoraj, James Young, Alexander C. Small, Evan Garden, Michael Palese
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The traditional cost of reusable cystoscopes (RC) is derived from up-front purchasing, repair fees and equipment reprocessing, whereas single-use, disposable cystoscopes ...
Publikováno v:
Urology Video Journal, Vol 10, Iss, Pp 100086-(2021)
Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology. Reply
Publikováno v:
Journal of Urology. 207:249-250
Autor:
Dimple Chakravarty, Parita Ratnani, Michael Palese, Ashutosh K. Tewari, Ivan Jambor, Nir Tomer, Zachary Dovey, Nihal Mohamed
Publikováno v:
Prostate cancer and prostatic diseases. 25(4)
INTRODUCTION Prostate cancer (PCa) is a heterogenous disease with multiple etiological factors playing a role in its development. Recently, chronic and systemic inflammatory conditions such as inflammatory bowel disease were identified as key risk fa
Publikováno v:
Urology. 131:21-23
Autor:
Parissa Tabrizian, Edward H. Chin, Benjamin Tran, Ron Shapiro, Michael Palese, Daniel M. Herron, Jake G. Prigoff, Matthew L. Holzner, Dianne LaPointe Rudow, Massimo Giacca, Sander Florman, Antonios Arvelakis
Publikováno v:
Progress in Transplantation. 29:283-286
Introduction: The benefit and short-term safety of ketorolac have been established in previous studies however, the risk of bleeding and long-term renal impairment in patients undergoing donor nephrectomy remain unclear. We report our experience at a
Autor:
Ketan K. Badani, Michael Palese, Aaron M. Fischman, Colton Welch, Reza Mehrazin, John J. Griffith, Zeynep Gul
Publikováno v:
Urology. 125:118-122
Objective To evaluate outcomes after focal ablative therapy for renal cell carcinoma (RCC) in transplant allograft kidneys. Methods After institutional review board approval, patients with a history of RCC in a transplanted allograft kidney who under